Albemarle Corporation
General ticker "ALB" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $12.7B (TTM average)
Albemarle Corporation follows the US Stock Market performance with the rate: 53.6%.
Estimated limits based on current volatility of 2.6%: low 186.24$, high 195.57$
Factors to consider:
- Earnings expected soon, date: 2026-05-06 amc
- Company included in S&P500 list
- Company pays dividends (irregularly): last record date 2026-03-13, amount 0.41$ (Y0.21%)
- Total employees count: 8300 as of 2024
- China accounted for 36.5% of revenue in the fiscal year ended 2024-12-31
- US accounted for 16.8% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Geopolitical risks, Raw material cost increases, Market demand fluctuations, Economic downturns and volatility, Environmental regulations
- Current price 75.4% above estimated high
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [59.02$, 116.36$]
- 2025-12-31 to 2026-12-31 estimated range: [56.44$, 110.54$]
Financial Metrics affecting the ALB estimates:
- Negative: with PPE of -38.2 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Positive: 42.60 < Shareholder equity ratio, % of 59.97 <= 64.25
- Positive: 6.68 < Operating cash flow per share per price, % of 6.68
- Positive: -0.01 < Industry operating cash flow per share per price (median), % of 4.95
- Positive: Interest expense per share per price, % of 1.58 <= 3.29
- Positive: 0.25 < Industry earnings per price (median), % of 2.08
- Positive: 3.02 < Industry operating profit margin (median), % of 6.40
Short-term ALB quotes
Long-term ALB plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $7,311.70MM | $9,688.39MM | $5,377.53MM |
| Operating Expenses | $4,841.64MM | $9,436.51MM | $7,154.07MM |
| Operating Income | $2,470.06MM | $251.88MM | $-1,776.55MM |
| Non-Operating Income | $-36.62MM | $-5.14MM | $12.72MM |
| Interest Expense | $122.97MM | $116.07MM | $165.62MM |
| R&D Expense | $71.98MM | $85.72MM | $86.72MM |
| Income(Loss) | $2,433.44MM | $246.74MM | $-1,763.83MM |
| Taxes | $390.59MM | $430.28MM | $87.08MM |
| Other Income(Loss) | $772.27MM | $1,854.08MM | $715.43MM |
| Profit(Loss)* | $2,689.82MM | $1,573.48MM | $-1,179.45MM |
| Stockholders Equity | $7,982.63MM | $9,412.18MM | $9,961.52MM |
| Inventory | $2,076.03MM | $2,161.29MM | $1,502.53MM |
| Assets | $15,456.52MM | $18,270.65MM | $16,609.65MM |
| Operating Cash Flow | $1,907.85MM | $1,325.32MM | $702.07MM |
| Capital expenditure | $1,261.65MM | $2,154.54MM | $1,680.53MM |
| Investing Cash Flow | $-1,422.65MM | $-2,781.16MM | $-1,574.44MM |
| Financing Cash Flow | $611.89MM | $623.91MM | $1,241.73MM |
| Earnings Per Share** | $22.97 | $13.41 | $-10.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.